Correlation Between FrontView REIT, and Lees Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both FrontView REIT, and Lees Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FrontView REIT, and Lees Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FrontView REIT, and Lees Pharmaceutical Holdings, you can compare the effects of market volatilities on FrontView REIT, and Lees Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FrontView REIT, with a short position of Lees Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of FrontView REIT, and Lees Pharmaceutical.
Diversification Opportunities for FrontView REIT, and Lees Pharmaceutical
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between FrontView and Lees is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding FrontView REIT, and Lees Pharmaceutical Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lees Pharmaceutical and FrontView REIT, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FrontView REIT, are associated (or correlated) with Lees Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lees Pharmaceutical has no effect on the direction of FrontView REIT, i.e., FrontView REIT, and Lees Pharmaceutical go up and down completely randomly.
Pair Corralation between FrontView REIT, and Lees Pharmaceutical
Considering the 90-day investment horizon FrontView REIT, is expected to generate 0.02 times more return on investment than Lees Pharmaceutical. However, FrontView REIT, is 62.36 times less risky than Lees Pharmaceutical. It trades about 0.0 of its potential returns per unit of risk. Lees Pharmaceutical Holdings is currently generating about -0.1 per unit of risk. If you would invest 1,900 in FrontView REIT, on September 28, 2024 and sell it today you would lose (13.00) from holding FrontView REIT, or give up 0.68% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 48.41% |
Values | Daily Returns |
FrontView REIT, vs. Lees Pharmaceutical Holdings
Performance |
Timeline |
FrontView REIT, |
Lees Pharmaceutical |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
FrontView REIT, and Lees Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with FrontView REIT, and Lees Pharmaceutical
The main advantage of trading using opposite FrontView REIT, and Lees Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FrontView REIT, position performs unexpectedly, Lees Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lees Pharmaceutical will offset losses from the drop in Lees Pharmaceutical's long position.FrontView REIT, vs. Chewy Inc | FrontView REIT, vs. Playstudios | FrontView REIT, vs. ATRenew Inc DRC | FrontView REIT, vs. Titan Machinery |
Lees Pharmaceutical vs. Transocean | Lees Pharmaceutical vs. Treasury Wine Estates | Lees Pharmaceutical vs. Vita Coco | Lees Pharmaceutical vs. Constellation Brands Class |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |